Developing mucosal vaccines for respiratory viruses

Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop. Researchers now explore the challenges and outline approaches to improved vaccines.

Leave a Comment

Your email address will not be published. Required fields are marked *